SCHEDULE: FMR LLC Boosts Legend Biotech Stake to 15%
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 15.0% of Legend Biotech Corp's common stock, totaling over 55 million shares.
Summary
- FMR LLC and Abigail P. Johnson, as reporting persons, have filed an Amendment No. 7 to Schedule 13G regarding their beneficial ownership in LEGEND BIOTECH CORP.
- They collectively beneficially own 55,093,683.70 shares of LEGEND BIOTECH CORP's common stock.
- This represents 15.0% of the total outstanding common stock of LEGEND BIOTECH CORP.
- FMR LLC holds sole voting power over 55,001,947.29 shares and sole dispositive power over 55,093,683.70 shares.
- Abigail P. Johnson, as a control person of FMR LLC, is also deemed to beneficially own the same aggregate amount of shares with sole dispositive power.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of LEGEND BIOTECH CORP.
- FMR LLC is classified as a parent holding company or control person, with several subsidiaries identified as investment advisers or banks, including Fidelity Management & Research Company LLC which beneficially owns 5% or greater of the outstanding shares.
Sentiment
Score: 6
Explanation: The filing is a neutral disclosure of beneficial ownership. The maintenance of a significant stake by a large institutional investor could be interpreted as a moderately positive signal of confidence, hence slightly above neutral.
Positives
- A major institutional investor, FMR LLC, maintains a significant 15.0% stake in LEGEND BIOTECH CORP, potentially signaling confidence in the company's long-term prospects.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
This filing indicates continued significant institutional interest in the biotechnology sector, with a major asset manager like FMR LLC maintaining a substantial stake in LEGEND BIOTECH CORP. Such large holdings by prominent investment firms can often be viewed as a vote of confidence in the company's specific therapeutic areas or overall market position within the competitive biotech landscape.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | NA | NA | NA | NA |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Ownership Structure Disclosure | Disclosure of the Johnson family's predominant ownership (49% voting power) of Series B voting common shares of FMR LLC and their shareholders' voting agreement, which forms a controlling group with respect to FMR LLC. | NA | Clarifies the internal control structure of the reporting entity, FMR LLC, which indirectly controls the reported shares in LEGEND BIOTECH CORP. This does not directly impact LEGEND BIOTECH CORP's corporate governance but provides transparency on the beneficial owner's internal structure. |
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: The disclosure of a significant 15.0% stake by a major institutional investor like FMR LLC may be viewed positively, potentially indicating institutional confidence in LEGEND BIOTECH CORP's value and future prospects.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event requiring the filing of this statement. |
| 11/04/2025 | Date of filing of this Schedule 13G. |
Keywords
LEGEND BIOTECH CORP, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, Biotech
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.